Nov 13, 2026AstraZeneca cuts 600 US sales jobs in respiratory and immunologyAstraZeneca has eliminated approximately 600 positions from its US respiratory and immunology commercial teams as part of a three-year cost-savings initiative.Nov 13, 2026·2 sources00
Nov 3, 2026Ultragenyx to cut 20% of workforce after Wilson disease gene therapy failureUltragenyx Therapeutics announced plans to lay off approximately 20% of its employees and discontinue development of its Wilson disease gene therapy GTX-102 following a major setback in Angelman syndrome trials.Nov 3, 2026·2 sources00
Oct 27, 2026Artiva discontinues cell therapy after two patient deaths, cuts workforce by 94%Artiva Biotherapeutics halted development of its experimental cell therapy for autoimmune conditions following two patient deaths in clinical trials and announced massive workforce reductions.Oct 27, 2026·4 sources00
Aug 24, 2026Bristol Myers ends blood cancer drug partnership with CellaresBristol Myers Squibb terminated its partnership with cell therapy startup Cellares to expand manufacturing of its personalized blood cancer therapy, prompting Cellares to lay off 100 employees.Aug 24, 2026·2 sources00
Jul 18, 2026Samsung Electronics America to reduce workforce by 739 in New JerseySamsung Electronics America is cutting 739 jobs in Englewood Cliffs, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) notice reviewed by Reuters.Jul 18, 2026·1 source00
Jun 26, 2026Biogen Scales Back Apellis Programs and Cuts Research Roles Following $5.6 Billion AcquisitionBiogen has paused or discontinued funding for most of Apellis Pharmaceuticals' research programs and is trimming research positions as it integrates the rare-disease drugmaker it acquired for $5.6 billion.Jun 26, 2026·1 source00